Terminated PHASE1 INTERVENTIONAL 2-arm NCT02115919

Safety Study of Multikine in the Treatment of Perianal Warts

Phase 1 Study of Multikine in the Treatment of Perianal Warts

Sponsor: CEL-SCI Corporation

Conditions Condyloma

Interventions Leukocyte Interleukin, Injection 200IU Leukocyte Interleukin, injection 400IU

Updated 6 times since 2017 Last updated: Aug 17, 2016 Started: Apr 30, 2014 Primary completion: Jan 31, 2016 Completion: Jan 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Unable to enroll prospective subject for dose escalation

Other terminated trials from CEL-SCI Corporation

Perianal Warts · Phase PHASE1 · Sep 2018

More terminations from CEL-SCI Corporation

A PHASE1 clinical study on Condyloma, this trial is terminated or withdrawn. The trial is conducted by CEL-SCI Corporation and has accumulated 6 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE1
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE1
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE1
Feb 2017 — Jun 2018 [monthly]

Terminated PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Terminated PHASE1

First recorded

Apr 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CEL-SCI Corporation
United States Naval Medical Center, San Diego

Data source: United States Naval Medical Center, San Diego

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• San Diego, United States